CIK: 1635088 - Address: 7Th Floor, 50 Broadway, London, X0 SW1H 0DB
24 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/15/25 16:36
1/13/25
IMVTImmunovant, Inc.D0HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0DTP336,90020.00016,8452196,650D
10/4/23 17:15
10/2/23
IMVTImmunovant, Inc.D0HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0DTP58,00038.0001,526279,805D
10/7/22 16:32
10/6/22
IMVTImmunovant, Inc.D0HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP2,5006.000417173,805D
9/4/20 17:29
9/4/20
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagRoivant Sciences Ltd.X0TP12,54033.000380147,593D
4/17/20 17:28
4/16/20
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagRoivant Sciences Ltd.X0TP15,00014.5001,034338,439D
2/27/20 19:49
2/24/20
AXGTAxovant Gene Therapies Ltd.HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP20,0003.7505,3334018,577D
12/18/19 16:28
12/16/19
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP.m3,76815.380245145,009D
12/4/19 18:08
12/2/19
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP.m4,58418.030254144,764D
11/27/19 16:45
11/25/19
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP52,50015.0003,500944,509D
11/22/19 21:28
11/20/19
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP.m3,02212.390244141,009D
6/19/19 18:00
6/17/19
UROVUrovant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP.m1518.32018022,860D
6/14/19 18:00
6/12/19
UROVUrovant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP.m1778.06022022,842D
6/11/19 18:00
6/7/19
UROVUrovant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP.m1778.31021022,820D
6/6/19 18:02
6/4/19
UROVUrovant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP.m1667.86021022,798D
6/6/19 18:00
6/4/19
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP20,0008.2502,424640,766D
6/3/19 19:15
5/30/19
UROVUrovant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP.m1397.83018022,777D
5/29/19 18:00
5/24/19
UROVUrovant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP.m1107.63014022,760D
5/23/19 18:00
5/21/19
UROVUrovant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP.m1638.22020022,745D
5/20/19 18:00
5/16/19
UROVUrovant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP.m1637.54022022,725D
3/19/19 16:18
3/18/19
AXONAxovant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP10,0001.5006,6677105,952D
12/20/18 06:02
12/18/18
AXONAxovant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP10,0001.00010,0001199,286D
10/3/18 16:48
10/1/18
UROVUrovant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP37,50014.0002,6791322,704D
6/7/18 07:31
6/5/18
AXONAxovant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP25,0001.75014,2861989,286D
4/4/18 16:52
4/2/18
MYOVMyovant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsRoivant Sciences Ltd.X0TP22,50020.2701,110338,341D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact